What is it about?
A commentary on a published study reporting that blue-blocking glasses are an effective adjuvant therapy for patients with acute bipolar mania. The study is the first randomized placebo-controlled trial that consolidates previous works with blue-blocking glasses as an additive treatment for mania.
Featured Image
Why is it important?
The work by Henriksen et al. can be considered to consolidate the role of intrinsically photosensitive retinal ganglion cells (ipRDCs) in mania and favors treatment approaches directly based on etiopathogenetic mechanisms of mania.
Perspectives
I highlight the work of Henriksen et al. that reported that blue-blocking glasses improve the symptoms of acute Bipolar Disorder mania and can be used as an adjuvant treatment in manic states.
Dr Amilcar Silva dos Santos
University of Lisbon
Read the Original
This page is a summary of: Commentary on ‘Blue-blocking glasses as additive treatment for mania: A randomized placebo-controlled trial’, Bipolar Disorders, December 2016, Wiley,
DOI: 10.1111/bdi.12458.
You can read the full text:
Contributors
The following have contributed to this page
